Therapeutic plasma exchange a potential strategy for patients with advanced heart failure

Journal of Clinical Apheresis

Volumn 25, Issue 6, 2010, Pages 323-330

  Torre Amione, Guillermo ^a,b   Orrego, Carlos M ^a   Khalil, Nashwa ^a   Kottner Assad, Christian ^a   Leveque, Christopher ^a   Celis, Rene ^a   Youker, Keith A ^a   Estep, Jerry D ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

Author keywords

heart failure; humoral immunity; therapeutic plasma exchange

Indexed keywords

ACUTE HEART FAILURE; ARTICLE; B LYMPHOCYTE; DISEASE SEVERITY; HEART MUSCLE; HUMAN; PLASMAPHERESIS;

ADULT; B-LYMPHOCYTES; CHRONIC DISEASE; FEMALE; HEART FAILURE; HUMANS; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYOCARDIUM; PLASMA EXCHANGE;

EID: 78650112379     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20264     Document Type: Article

References (45)

1. Kaya Z, Afanasyeva M, Wang Y, Dohmen KM, Schlichting J, Tretter T, Fairweather D, Holers VM, Rose NR,. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol 2001; 2: 739-745.
2. Kasahara H, Itoh M, Sugiyama T, Kido N, Hayashi H, Saito H, Tsukita S, Kato N,. Autoimmune myocarditis induced in mice by cardiac C-protein. Cloning of complementary DNA encoding murine cardiac C-protein and partial characterization of the antigenic peptides. J Clin Investig 1994; 94: 1026-1036.
3. Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B,. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation 1998; 97: 1375-1381.
4. Murray DR, Freeman GL,. Tumor necrosis factor-alpha induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 1996; 78: 154-160.
5. Benigni F, Sacco S, Pennica D, Ghezzi P,. Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells. Am J Pathol 1996; 149: 1847-1850.
6. Satoh M, Iwasaka J, Nakamura M, Akatsu T, Shimoda Y, Hiramori K,. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure. Eur J Heart Fail 2004; 6: 869-875.
7. Yamaoka M, Yamaguchi S, Okuyama M, Tomoike H,. Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha. Jpn Circ J 1999; 63: 951-956.
8. Kubota T, Miyagishima M, Alvarez RJ, Kormos R, Rosenblum WD, Demetris AJ, Semigran MJ, Dec GW, Holubkov R, McTiernan CF, Mann DL, Feldman AM, McNamara DM,. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant 2000; 19: 819-824.
9. Lommi J, Pulkki K, Koskinen P, Näveri H, Leinonen H, Härkönen M, Kupari M,. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur Heart J 1997; 18: 1620-1625.
10. Mann DL, Young JB,. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest 1994; 105: 897-904.
11. Sato Y, Takatsu Y, Kataoka K, Yamada T, Taniguchi R, Sasayama S, Matsumori A,. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 1999; 22: 811-813.
12. Torre-Amione G, Vooletich MT, Farmer JA,. Role of tumour necrosis factor-alpha in the progression of heart failure: therapeutic implications. Drugs 2000; 59: 745-751.
13. Heberto Herrera Garza E, Herrera Garza JL, Rodriguez Gonzalez H, Trevino Trevino A, Ibarra Flores M, Torre Amione G,. Importance of tumor necrosis factor-alpha in the pathogenesis of heart failure. Rev Espanola Cardiol 2002; 55: 61-66.
14. Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL,. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation 2001; 103: 1044-1047.
15. Anker SD, Coats AJ,. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL, and ATTACH. Int J Cardiol 2002; 86: 123-130.
16. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS, Djian J, Drexler H, Feldman A, Kober L, Krum H, Liu P, Nieminen M, Tavazzi L, van Veldhuisen DJ, Waldenstrom A, Warren M, Westheim A, Zannad F, Fleming T,. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 2004; 109: 1594-1602.
17. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT,. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 2003; 107: 3133-3140.
18. Jose PJ,. Complement-derived peptide mediators of inflammation. Br Med Bull 1987; 43: 336-343.
19. Clark DJ, Cleman MW, Pfau SE, Rollins SA, Ramahi TM, Mayer C, Caulin-Glaser T, Daher E, Kosiborod M, Bell L, Setaro JF,. Serum complement activation in congestive heart failure. Am Heart J 2001; 141: 684-690.
20. Jahns R, Boivin V, Hein L, Triebel S, Angermann CE, Ertl G, Lohse MJ,. Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Investig 2004; 113: 1419-1429.
21. Freedman NJ, Lefkowitz RJ,. Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Investig 2004; 113: 1379-1382.
22. Tonevitskii AG, Tabak'an EA,. The role of anti-beta1-adrenergic receptor autoantibodies in development of heart failure. Rossiiskii fiziologicheskii zhurnal imeni IM 2006; 92: 330-241.
23. Donermeyer DL, Beisel KW, Allen PM, Smith SC,. Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J Exp Med 1995; 182: 1291-1300.
24. Cunningham MW,. T cell mimicry in inflammatory heart disease. Mol Immunol 2004; 40: 1121-1127.
25. Pummerer CL, Luze K, Grassl G, Bachmaier K, Offner F, Burrell SK, Lenz DM, Zamborelli TJ, Penninger JM, Neu N,. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J Clin Investig 1996; 97: 2057-2062.
26. Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahlne A, Guillet JG, Strosberg AD, Hjalmarson A, Hoebeke J,. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Investig 1990; 86: 1658-1663.
27. Wallukat G, Muller J, Podlowski S, Nissen E, Morwinski R, Hetzer R,. Agonist-like beta-adrenoceptor antibodies in heart failure. Am J Cardiol 1999; 83: 75H-79H.
28. Muller J, Wallukat G, Dandel M, Bieda H, Brandes K, Spiegelsberger S, Nissen E, Kunze R, Hetzer R,. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000; 101: 385-391.
29. Wang Z, Liao Y, Dong J, Li S, Wang J, Tu Y,. Myosin-induced autoimmune myocarditis in BALB/C mice. J Tongji Med Univ (Tong ji yi ke da xue xue bao) 1999; 19: 112-114.
30. Wang Z, Liao Y, Dong J, Li S, Wang J, Fu ML,. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy. Chin Med J 2003; 116: 499-502.
31. Neu N, Ploier B,. Experimentally-induced autoimmune myocarditis: production of heart myosin-specific autoantibodies within the inflammatory infiltrate. Autoimmunity 1991; 8: 317-322.
32. Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A,. Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol 2007; 49: 1684-1692.
33. Limas CJ, Goldenberg IF, Limas C,. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. Circ Res 1989; 64: 97-103.
34. Wallukat G, Morwinski M, Kowal K, Forster A, Boewer V, Wollenberger A,. Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization. Eur Heart J 1991; 12 (Suppl D): 178-181.
35. Warraich RS, Dunn MJ, Yacoub MH,. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients. Biochem Biophys Res Commun 1999; 259: 255-261.
36. Lauer B, Padberg K, Schultheiss HP, Strauer BE,. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis. J Am Coll Cardiol 1994; 23: 146-153.
37. Lauer B, Padberg K, Schultheiss HP, Strauer BE,. Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy. Zeitschrift fur Kardiol 1995; 84: 301-310.
38. Felix SB, Dorr M, Herda LR, Beug D, Staudt A,. Immunoadsorption for treatment of dilated cardiomyopathy. Der Internist 2008; 49: 51-56.
39. Knebel F, Bohm M, Staudt A, Borges AC, Tepper M, Jochmann N, Wernicke KD, Felix S, Baumann G,. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy. Int J Cardiol 2004; 97: 517-520.
40. Staudt A, Hummel A, Ruppert J, Dörr M, Trimpert C, Birkenmeier K, Krieg T, Staudt Y, Felix SB,. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study. Am Heart J 2006; 152: e712-e716.
41. Kiprov DD, Hofmann JC,. Therapeutic plasma exchange in immunologically mediated polyneuropathies. Ther Apher Dial 2003; 7: 189-196.
42. Papazian O, Alfonso I,. Acute autoimmune polyradiculoneuropathies. Rev Neurol 2002; 34: 169-177.
43. Schneider KM,. Therapeutic plasma exchange and immunoadsorption: different techniques and their current role in medical therapy. Kid Int 1998; 64: S61-S65.
44. Turner AN,. Goodpasture's disease. Nephrol Dial Transplant 2001; 16 (Suppl 6): 52-54.
45. Gullestad L, Aass H, Fjeld JG, Wikeby L, Andreassen AK, Ihlen H, Simonsen S, Kjekshus J, Nitter-Hauge S, Ueland T, Lien E, Frøland SS, Aukrust P,. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 2001; 103: 220-225. (Pubitemid 32095406)